- $4.45bn
- $5.35bn
- $3.19bn
REG - Lazard Asset Mgmnt Xeris Pharmaceutical - Form 8.3 - Xeris Pharmaceuticals, Inc.
AnnouncementREG - Dr. Martens PLC - Approval and Publication of Prospectus
AnnouncementREG - Dr. Martens PLC - Announcement of Offer Price
AnnouncementREG - Dr. Martens Limited - Confirmation of Intention to Float
AnnouncementREG - Lazard Asset Mgmnt KAZ Minerals PLC - Form 8.3 - KAZ Minerals PLC
AnnouncementREG - Zambia (Republic of) - Q&A Follow-up to Presentation to Creditors
AnnouncementREG - Daejan Hldgs PLC - Cancellation of listing & trading of Daejan Shares
AnnouncementREG - Lazard Asset Mgmnt Aon PLC - Form 8.3 - AON Plc
AnnouncementREG - Lazard Asset Mgmnt Aon PLC - Form 8.3 - AON Plc
AnnouncementREG - Lazard Asset Mgmnt Aon PLC - Form 8.3 - AON Plc
AnnouncementREG - Lazard Asset Mgmnt Aon PLC - Form 8.3 - AON Plc/Ireland
AnnouncementREG - Lazard Asset Mgmnt Aon PLC - Form 8.3 - AON Plc
AnnouncementREG - Lazard Asset Mgmnt Aon PLC - Form 8.3 - AON Plc
AnnouncementREG - Sirius Minerals plc - Scheme becomes effective
AnnouncementREG - Thoma Bravo LLC Sophos Group Plc - Average Market Exchange Rate
AnnouncementREG - Indept. News & Media Indept. News & Media - Publication of Scheme Document
AnnouncementREG - Debenhams plc - £200m refinancing completed
AnnouncementREG - Lazard World Tst Fnd - September 2018 Fact Sheet
Announcement